Belite Financial Statements From 2010 to 2025

BLTE Stock  USD 68.38  0.57  0.84%   
Belite Bio financial statements provide useful quarterly and yearly information to potential Belite Bio ADR investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Belite Bio financial statements helps investors assess Belite Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Belite Bio's valuation are summarized below:
Market Capitalization
2.2 B
Earnings Share
(1.18)
There are over one hundred sixteen available fundamental signals for Belite Bio ADR, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Belite Bio's prevailing performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road. As of March 19, 2025, Enterprise Value is expected to decline to about 291.2 M
Check Belite Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Belite Bio's main balance sheet or income statement drivers, such as Tax Provision of 5.5 K, Net Interest Income of 3.9 M or Interest Income of 3.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Ptb Ratio of 12.71 or Days Sales Outstanding of 0.0. Belite financial statements analysis is a perfect complement when working with Belite Bio Valuation or Volatility modules.
  
Check out the analysis of Belite Bio Correlation against competitors.

Belite Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets159.7 M152.1 M47 M
Slightly volatile
Short and Long Term Debt Total757.5 K797.4 K24.1 M
Slightly volatile
Other Current Liabilities274.6 K289 K1.1 M
Pretty Stable
Total Current Liabilities3.2 MM1.7 M
Slightly volatile
Property Plant And Equipment Net836.9 K965 K331.3 K
Slightly volatile
Cash45.1 M31.7 M31.6 M
Slightly volatile
Non Current Assets Total2.7 M5.1 M977.2 K
Slightly volatile
Non Currrent Assets Other210.6 K149.4 K92.7 K
Slightly volatile
Cash And Short Term Investments106.4 M101.4 M39.8 M
Slightly volatile
Net ReceivablesM997 K212.1 K
Slightly volatile
Common Stock Shares Outstanding27.8 M31.8 M24.7 M
Slightly volatile
Liabilities And Stockholders Equity114.3 M108.8 M41.5 M
Slightly volatile
Non Current Liabilities Total247.9 K261 K24 M
Slightly volatile
Other Current Assets1.1 M1.1 M246.8 K
Slightly volatile
Other Stockholder Equity196 M186.7 M47.2 M
Slightly volatile
Total LiabilitiesM6.3 M25.8 M
Slightly volatile
Property Plant And Equipment Gross992.6 K1.3 M414 K
Slightly volatile
Total Current Assets154.4 M147.1 M45.9 M
Slightly volatile
Capital Stock2.4 K3.5 K1.5 K
Slightly volatile
Net Working Capital148.1 M141 M44 M
Slightly volatile
Common Stock2.2 K3.5 K1.5 K
Slightly volatile
Property Plant Equipment77 K108.1 K60.8 K
Slightly volatile
Deferred Long Term Liabilities652 K733.5 K799.7 K
Slightly volatile
Short Term Debt281.6 K277.2 K375.9 K
Slightly volatile
Intangible Assets2.7 MM643.1 K
Slightly volatile

Belite Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.9 M3.7 M493.4 K
Slightly volatile
Depreciation And Amortization105.6 K159.8 K51.2 K
Slightly volatile
Interest Expense19.1 K20 K19.8 K
Pretty Stable
Selling General Administrative5.6 M10.1 M3.2 M
Slightly volatile
Other Operating Expenses38.2 M36.4 M12 M
Slightly volatile
Research Development16.4 M29.9 MM
Slightly volatile
Cost Of Revenue481.8 K458.9 K109.7 K
Slightly volatile
Total Operating Expenses22 M40 M11.2 M
Slightly volatile
Reconciled Depreciation240.5 K449 K94 K
Slightly volatile
Selling And Marketing Expenses319.2 K359.1 K391.5 K
Slightly volatile

Belite Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation9.4 MM2.5 M
Slightly volatile
Begin Period Cash Flow92.6 M88.2 M18 M
Slightly volatile
Depreciation240.5 K449 K94 K
Slightly volatile
Capital Expenditures154.4 K151 K66 K
Slightly volatile
End Period Cash Flow45.1 M31.7 M31.6 M
Slightly volatile
Change To Netincome1.6 M1.8 M1.4 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.320.33631.1382
Pretty Stable
Cash Per Share3.132.981.4967
Slightly volatile
Income Quality0.670.80880.7872
Pretty Stable
Intangibles To Total Assets0.01630.02620.0054
Slightly volatile
Current Ratio17.0424.309624.2246
Slightly volatile
Capex Per Share0.0020.00210.0024
Slightly volatile
Interest Debt Per Share0.03740.03941.0003
Slightly volatile
Debt To Assets0.00340.00350.9601
Slightly volatile
Ebt Per Ebit1.091.151.0143
Slightly volatile
Total Debt To Capitalization0.00350.00371.0041
Slightly volatile
Quick Ratio17.0424.309624.2252
Slightly volatile
Net Income Per E B T1.11.151.0157
Slightly volatile
Cash Ratio4.975.235922.1875
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.00521.0132
Slightly volatile
Debt Ratio0.00340.00350.9601
Slightly volatile

Belite Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap296.7 M542 M319.1 M
Slightly volatile
Enterprise Value291.2 M504.9 M316.4 M
Slightly volatile

Belite Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Belite Bio Financial Statements

Belite Bio stakeholders use historical fundamental indicators, such as Belite Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Belite Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Belite Bio's assets and liabilities are reflected in the revenues and expenses on Belite Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Belite Bio ADR. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue458.9 K481.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:
Check out the analysis of Belite Bio Correlation against competitors.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.18)
Return On Assets
(0.26)
Return On Equity
(0.40)
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.